NASDAQ · ZURA
Zura Bio Limited
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for ZURA has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.19 | $-0.13 | $-0.24 | 4 |
| Mar 2027 | $-0.17 | $-0.07 | $-0.25 | 4 |
| Jun 2027 | $-0.17 | $-0.06 | $-0.26 | 4 |
| Sep 2027 | $-0.17 | $-0.07 | $-0.25 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · Quiver Quantitative- RTTNews · Oct 27, 3:28 PM EDTBiotech Stocks Move Higher: ZURA Surges 21%, PLUR Gains 13%, WVE Rises 7%, KNSA Advances(RTTNews) – Shares of several biotech companies moved higher following quarterly financial results, clinical pipeline updates and strategic developments. Kiniksa Pharmaceuticals raised its 2026 ARCALYST revenue outlook, Pluri announced a U.S. commercialization partnership with ZE
- RTTNews · Aug 12, 9:12 AM EDTZura Reports Wider Loss In Q2; Expects Phase 2 TibuSHIELD Data In Q2 2026(RTTNews) – Zura Bio Limited (ZURA) a biotech company, announced financial results for the second quarter, reflecting a loss wider than a year ago, driven in part by higher Research and Development (R&D) expenses.
- RTTNews · Jun 30, 1:25 AM EDTTenaya Therapeutics Names Eric Hyllengren CFO Ahead Of Higa Retirement(RTTNews) – Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 13, 2026, following the planned retirement of Hiro Higa, Senior Vice President of Finance, in the third qu
- RTTNews · Jun 29, 10:09 AM EDTTenaya Therapeutics Appoints Eric Hyllengren As Chief Financial Officer(RTTNews) – Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, said on Monday that it has appointed Eric Hyllengren as Chief Financial Officer with effect from July 13.
- Fintel · Feb 9, 7:04 PM ESTWedbush Initiates Coverage of Zura Bio (ZURA) with Outperform RecommendationFintel reports that on February 9, 2026, Wedbush initiated coverage of Zura Bio (NasdaqCM:ZURA) with a Outperform recommendation. Analyst Price Forecast Suggests 159.87% Upside
- Fintel · Dec 6, 5:53 AM ESTZura Bio (ZURA) Price Target Increased by 20.00% to 16.32The average one-year price target for Zura Bio (NasdaqCM:ZURA) has been revised to $16.32 / share. This is an increase of 20.00% from the prior estimate of $13.60 dated November 14, 2025. The price target is an average of many targets provided by analysts. The
- Fintel · Nov 15, 7:03 AM ESTChardan Capital Maintains Zura Bio (ZURA) Buy RecommendationFintel reports that on November 14, 2025, Chardan Capital maintained coverage of Zura Bio (NasdaqCM:ZURA) with a Buy recommendation. Analyst Price Forecast Suggests 233.33% Upside
- Fintel · Nov 13, 7:03 AM ESTClear Street Initiates Coverage of Zura Bio (ZURA) with Buy RecommendationFintel reports that on November 13, 2025, Clear Street initiated coverage of Zura Bio (NasdaqCM:ZURA) with a Buy recommendation. Analyst Price Forecast Suggests 193.74% Upside
- RTTNews · Oct 24, 12:20 AM EDTINBX Soars 81% Post-Study; FEMY, CING, CYH Pop After Hours(RTTNews) – Biotech stocks led the after-hours charge on Thursday, with Inhibrx Biosciences (INBX) skyrocketing over 81% on positive Phase 2 trial results in chondrosarcoma. Femasys (FEMY), Cingulate (CING), and Community Health Systems (CYH) also posted notable gains, driven by
- RTTNews · Oct 7, 8:44 AM EDTZura's Make-or-Break Year Ahead: Will TibuSHIELD And TibuSURE Trials Deliver Or Disappoint?(RTTNews) – 2026 could be a pivotal year for Zura Bio Ltd. (ZURA), with key data readouts for its lead investigational drug expected to significantly influence the company's strategic direction and market position.
- Quiver Quantitative · May 8, 6:55 AM EDTZURA BIO Earnings Results: $ZURA Reports Quarterly EarningsZURA BIO ($ZURA) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.19 per share, missing estimates of -$0.15 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.
- Quiver Quantitative · Apr 7, 12:21 PM EDTNew Analyst Forecast: $ZURA Given $3.0 Price TargetWe just received data on a new analyst forecast for $ZURA. Mitchell Kapoor from H.C. Wainwright set a price target of 3.0 for ZURA.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Zura Bio Limited from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.